Condition: Acute Lymphoblastic Leukemia · Lymphoblastic Lymphoma · Sponsor: Northwestern University
This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.
This description comes directly from the study's public registry record.
Alexandra M Psihogios, Ph.D. · 312-503-3577 · alex.psihogios@northwestern.edu
Always discuss trial participation with your own doctor first.
| Robert H. Lurie Comprehensive Cancer Center, Northwestern University | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03932903